FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization

Fibroblast growth factor receptor 1 (FGFR1) transmits signals through the plasma membrane regulating essential cellular processes like division, motility, metabolism, and death. Overexpression of FGFR1 is observed in numerous tumors and thus constitutes an attractive molecular target for selective c...

Full description

Bibliographic Details
Main Authors: Marta Pozniak, Aleksandra Sokolowska‐Wedzina, Kamil Jastrzebski, Jakub Szymczyk, Natalia Porebska, Mateusz Adam Krzyscik, Malgorzata Zakrzewska, Marta Miaczynska, Jacek Otlewski, Lukasz Opalinski
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.12740
_version_ 1818275139446374400
author Marta Pozniak
Aleksandra Sokolowska‐Wedzina
Kamil Jastrzebski
Jakub Szymczyk
Natalia Porebska
Mateusz Adam Krzyscik
Malgorzata Zakrzewska
Marta Miaczynska
Jacek Otlewski
Lukasz Opalinski
author_facet Marta Pozniak
Aleksandra Sokolowska‐Wedzina
Kamil Jastrzebski
Jakub Szymczyk
Natalia Porebska
Mateusz Adam Krzyscik
Malgorzata Zakrzewska
Marta Miaczynska
Jacek Otlewski
Lukasz Opalinski
author_sort Marta Pozniak
collection DOAJ
description Fibroblast growth factor receptor 1 (FGFR1) transmits signals through the plasma membrane regulating essential cellular processes like division, motility, metabolism, and death. Overexpression of FGFR1 is observed in numerous tumors and thus constitutes an attractive molecular target for selective cancer treatment. Targeted anti‐cancer therapies aim for the precise delivery of drugs into cancer cells, sparing the healthy ones and thus limiting unwanted side effects. One of the key steps in targeted drug delivery is receptor‐mediated endocytosis. Here, we show that the efficiency and the mechanism of FGFR1 internalization are governed by the spatial distribution of the receptor in the plasma membrane. Using engineered antibodies of different valency, we demonstrate that dimerization of FGFR1 with bivalent antibody triggers clathrin‐mediated endocytosis (CME) of the receptor. Clustering of FGFR1 into larger oligomers with tetravalent antibody stimulates fast and highly efficient uptake of the receptor that occurs via two distinct mechanisms: CME and dynamin‐dependent clathrin‐independent endocytic routes. Furthermore, we show that all endocytic pathways engaged in FGFR1 internalization do not require receptor activation. Our data provide novel insights into the mechanisms of intracellular trafficking of FGFR1 and constitute guidelines for development of highly internalizing antibody‐based drug carriers for targeted therapy of FGFR1‐overproducing cancers.
first_indexed 2024-12-12T22:25:00Z
format Article
id doaj.art-41add822f32c4099b544103cf1062b2c
institution Directory Open Access Journal
issn 1574-7891
1878-0261
language English
last_indexed 2024-12-12T22:25:00Z
publishDate 2020-09-01
publisher Wiley
record_format Article
series Molecular Oncology
spelling doaj.art-41add822f32c4099b544103cf1062b2c2022-12-22T00:09:47ZengWileyMolecular Oncology1574-78911878-02612020-09-011491998202110.1002/1878-0261.12740FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalizationMarta Pozniak0Aleksandra Sokolowska‐Wedzina1Kamil Jastrzebski2Jakub Szymczyk3Natalia Porebska4Mateusz Adam Krzyscik5Malgorzata Zakrzewska6Marta Miaczynska7Jacek Otlewski8Lukasz Opalinski9Faculty of Biotechnology Department of Protein Engineering University of Wroclaw PolandFaculty of Biotechnology Department of Protein Engineering University of Wroclaw PolandLaboratory of Cell Biology International Institute of Molecular and Cell Biology PolandFaculty of Biotechnology Department of Protein Engineering University of Wroclaw PolandFaculty of Biotechnology Department of Protein Engineering University of Wroclaw PolandFaculty of Biotechnology Department of Protein Engineering University of Wroclaw PolandFaculty of Biotechnology Department of Protein Engineering University of Wroclaw PolandLaboratory of Cell Biology International Institute of Molecular and Cell Biology PolandFaculty of Biotechnology Department of Protein Engineering University of Wroclaw PolandFaculty of Biotechnology Department of Protein Engineering University of Wroclaw PolandFibroblast growth factor receptor 1 (FGFR1) transmits signals through the plasma membrane regulating essential cellular processes like division, motility, metabolism, and death. Overexpression of FGFR1 is observed in numerous tumors and thus constitutes an attractive molecular target for selective cancer treatment. Targeted anti‐cancer therapies aim for the precise delivery of drugs into cancer cells, sparing the healthy ones and thus limiting unwanted side effects. One of the key steps in targeted drug delivery is receptor‐mediated endocytosis. Here, we show that the efficiency and the mechanism of FGFR1 internalization are governed by the spatial distribution of the receptor in the plasma membrane. Using engineered antibodies of different valency, we demonstrate that dimerization of FGFR1 with bivalent antibody triggers clathrin‐mediated endocytosis (CME) of the receptor. Clustering of FGFR1 into larger oligomers with tetravalent antibody stimulates fast and highly efficient uptake of the receptor that occurs via two distinct mechanisms: CME and dynamin‐dependent clathrin‐independent endocytic routes. Furthermore, we show that all endocytic pathways engaged in FGFR1 internalization do not require receptor activation. Our data provide novel insights into the mechanisms of intracellular trafficking of FGFR1 and constitute guidelines for development of highly internalizing antibody‐based drug carriers for targeted therapy of FGFR1‐overproducing cancers.https://doi.org/10.1002/1878-0261.12740CIECMEendocytosisFGFRprotein transportsignaling
spellingShingle Marta Pozniak
Aleksandra Sokolowska‐Wedzina
Kamil Jastrzebski
Jakub Szymczyk
Natalia Porebska
Mateusz Adam Krzyscik
Malgorzata Zakrzewska
Marta Miaczynska
Jacek Otlewski
Lukasz Opalinski
FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
Molecular Oncology
CIE
CME
endocytosis
FGFR
protein transport
signaling
title FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
title_full FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
title_fullStr FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
title_full_unstemmed FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
title_short FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
title_sort fgfr1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
topic CIE
CME
endocytosis
FGFR
protein transport
signaling
url https://doi.org/10.1002/1878-0261.12740
work_keys_str_mv AT martapozniak fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization
AT aleksandrasokolowskawedzina fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization
AT kamiljastrzebski fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization
AT jakubszymczyk fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization
AT nataliaporebska fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization
AT mateuszadamkrzyscik fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization
AT malgorzatazakrzewska fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization
AT martamiaczynska fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization
AT jacekotlewski fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization
AT lukaszopalinski fgfr1clusteringwithengineeredtetravalentantibodyimprovestheefficiencyandmodifiesthemechanismofreceptorinternalization